Elicio Therapeutics, Inc. Preferred Stock, Shares Outstanding
Elicio Therapeutics, Inc. (ELTX) had Preferred Stock, Shares Outstanding of 0 shares as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-03-12
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-12 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |